510 related articles for article (PubMed ID: 2356856)
41. Platelet releasate treatment improves skin healing in diabetic rats through endogenous growth factor secretion.
Moulin V; Lawny F; Barritault D; Caruelle JP
Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):961-71. PubMed ID: 9763200
[TBL] [Abstract][Full Text] [Related]
42. Healing of full-thickness wounds treated with lyophilized cultured keratinocyte cell lysate in genetically diabetic mice.
Roseeuw DI; de Coninck AL; Vanpée ES; Delaey BM; Verbeken GL; Draye JP
Wound Repair Regen; 1995; 3(4):500-5. PubMed ID: 17147662
[TBL] [Abstract][Full Text] [Related]
43. Effects of plasma fibronectin on the healing of full-thickness skin wounds in streptozotocin-induced diabetic rats.
Qiu Z; Kwon AH; Kamiyama Y
J Surg Res; 2007 Mar; 138(1):64-70. PubMed ID: 17161431
[TBL] [Abstract][Full Text] [Related]
44. Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis.
McLaughlin PJ; Immonen JA; Zagon IS
Exp Biol Med (Maywood); 2013 Jul; 238(7):733-43. PubMed ID: 23788174
[TBL] [Abstract][Full Text] [Related]
45. Accelerated healing of excisional skin wounds by PL 14736 in alloxan-hyperglycemic rats.
Seveljević-Jaran D; Cuzić S; Dominis-Kramarić M; Glojnarić I; Ivetić V; Radosević S; Parnham MJ
Skin Pharmacol Physiol; 2006; 19(5):266-74. PubMed ID: 16785777
[TBL] [Abstract][Full Text] [Related]
46. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice.
Tsuboi R; Rifkin DB
J Exp Med; 1990 Jul; 172(1):245-51. PubMed ID: 2358777
[TBL] [Abstract][Full Text] [Related]
47. Growth factor impact on wound healing.
Servold SA
Clin Podiatr Med Surg; 1991 Oct; 8(4):937-53. PubMed ID: 1933739
[TBL] [Abstract][Full Text] [Related]
48. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model.
Mustoe TA; Pierce GF; Morishima C; Deuel TF
J Clin Invest; 1991 Feb; 87(2):694-703. PubMed ID: 1991853
[TBL] [Abstract][Full Text] [Related]
49. Nanotechnology promotes the full-thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats.
Chu Y; Yu D; Wang P; Xu J; Li D; Ding M
Wound Repair Regen; 2010; 18(5):499-505. PubMed ID: 20840519
[TBL] [Abstract][Full Text] [Related]
50. The effect of epidermal growth factor & platelet-derived growth factors on wound healing process.
Gope R
Indian J Med Res; 2002 Nov; 116():201-6. PubMed ID: 12710550
[TBL] [Abstract][Full Text] [Related]
51. Syndecan-4 enhances PDGF-BB activity in diabetic wound healing.
Das S; Majid M; Baker AB
Acta Biomater; 2016 Sep; 42():56-65. PubMed ID: 27381525
[TBL] [Abstract][Full Text] [Related]
52. Topical growth factors and wound contraction in the rat: Part II. Platelet-derived growth factor and wound contraction in normal and steroid-impaired rats.
Engrav LH; Richey KJ; Kao CC; Murray MJ
Ann Plast Surg; 1989 Sep; 23(3):245-8. PubMed ID: 2782825
[TBL] [Abstract][Full Text] [Related]
53. Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects.
Marden LJ; Fan RS; Pierce GF; Reddi AH; Hollinger JO
J Clin Invest; 1993 Dec; 92(6):2897-905. PubMed ID: 8254045
[TBL] [Abstract][Full Text] [Related]
54. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis.
Asai J; Takenaka H; Hirakawa S; Sakabe J; Hagura A; Kishimoto S; Maruyama K; Kajiya K; Kinoshita S; Tokura Y; Katoh N
Am J Pathol; 2012 Dec; 181(6):2217-24. PubMed ID: 23138019
[TBL] [Abstract][Full Text] [Related]
55. PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds.
Park SA; Raghunathan VK; Shah NM; Teixeira L; Motta MJ; Covert J; Dubielzig R; Schurr M; Isseroff RR; Abbott NL; McAnulty J; Murphy CJ
PLoS One; 2014; 9(8):e104447. PubMed ID: 25121729
[TBL] [Abstract][Full Text] [Related]
56. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.
Mustoe TA; Cutler NR; Allman RM; Goode PS; Deuel TF; Prause JA; Bear M; Serdar CM; Pierce GF
Arch Surg; 1994 Feb; 129(2):213-9. PubMed ID: 8304833
[TBL] [Abstract][Full Text] [Related]
57. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.
Robson MC; Phillips LG; Thomason A; Robson LE; Pierce GF
Lancet; 1992 Jan; 339(8784):23-5. PubMed ID: 1345953
[TBL] [Abstract][Full Text] [Related]
58. Platelet-derived growth factor and impaired wound healing.
Sprugel KH; Greenhalgh DG; Murray MJ; Ross R
Prog Clin Biol Res; 1991; 365():327-40. PubMed ID: 1862143
[No Abstract] [Full Text] [Related]
59. Synergistic actions of platelet-derived growth factor and the insulin-like growth factors in vivo.
Greenhalgh DG; Hummel RP; Albertson S; Breeden MP
Wound Repair Regen; 1993; 1(2):69-81. PubMed ID: 17134386
[TBL] [Abstract][Full Text] [Related]
60. Basic fibroblast growth factor accelerates tissue repair in models of impaired wound healing.
Klingbeil CK; Cesar LB; Fiddes JC
Prog Clin Biol Res; 1991; 365():443-58. PubMed ID: 1862149
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
